tradingkey.logo
tradingkey.logo
Buscar

iRhythm Technologies Inc

IRTC
Añadir a la lista de seguimiento
118.950USD
+0.530+0.45%
Cierre 06/30, 16:00ETCotizaciones retrasadas 15 min
3.91BCap. mercado
PérdidaP/E TTM

Más Datos de iRhythm Technologies Inc Compañía

iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry (MCT) monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.

Información de iRhythm Technologies Inc

Símbolo de cotizaciónIRTC
Nombre de la empresaiRhythm Technologies Inc
Fecha de salida a bolsaOct 20, 2016
Director ejecutivoBlackford (Quentin S)
Número de empleados2000
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 20
Dirección699 8th Street
CiudadSAN FRANCISCO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94103
Teléfono14156325700
Sitio Webhttps://www.irhythmtech.com/
Símbolo de cotizaciónIRTC
Fecha de salida a bolsaOct 20, 2016
Director ejecutivoBlackford (Quentin S)

Ejecutivos de iRhythm Technologies Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
120.88K
+0.15%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
40.03K
-4.29%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
26.55K
+0.52%
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
23.03K
-17.10%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
20.51K
+7.67%
Mr. Bruce G. Bodaken
Mr. Bruce G. Bodaken
Independent Director
Independent Director
12.85K
+12.24%
Mr. Daniel G. (Dan) Wilson
Mr. Daniel G. (Dan) Wilson
Chief Financial Officer
Chief Financial Officer
12.26K
-35.00%
Dr. Ralph Snyderman, M.D.
Dr. Ralph Snyderman, M.D.
Independent Director
Independent Director
11.45K
+11.86%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
9.78K
+16.08%
Dr. Cathleen Noel Bairey Merz, M.D.
Dr. Cathleen Noel Bairey Merz, M.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
120.88K
+0.15%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
40.03K
-4.29%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
26.55K
+0.52%
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
23.03K
-17.10%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
20.51K
+7.67%
Mr. Bruce G. Bodaken
Mr. Bruce G. Bodaken
Independent Director
Independent Director
12.85K
+12.24%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de iRhythm Technologies Inc?

Los cinco principales accionistas de iRhythm Technologies Inc son: Mr. Quentin S. Blackford

¿Cuántas instituciones poseen acciones de iRhythm Technologies Inc (IRTC)?

A fecha de 2026Q1, 673 instituciones poseen acciones de iRhythm Technologies Inc, con un valor de mercado combinado de aproximadamente 35.19M, lo que representa el 107.08% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -2933991.00.

¿Cuál es la mayor fuente de ganancias de iRhythm Technologies Inc?

El 2026Q1, el segmento empresarial Commercial Payors generó la ganancia más alta para iRhythm Technologies Inc, ascendiendo a 392.23M y representando el 52.50% de la ganancia total.